Raia Drogasil (RADLY)

Overall impact
B (72)

Commentary

Raia Drogasil is a strong overall performer. With a 'B' rating of 71.7 for overall impact (85th percentile compared to all companies), Raia Drogasil ranks 1st out of 19 industry peers, ahead of GNC, HealthWarehouse.com, Petmed Express and 15 others. On top material causes for Raia Drogasil's industry (Drug Retailers), Raia Drogasil performs well in Sustainable Use of Natural Resources (95.4 score), Reduced Green House Gas Emissions (85.4), Child and Maternal Health (95.8) and 5 other causes where it received an 'A' score and performs poorly in Reduced Use of tobacco (32.6 score) and Humane Treatment of Animals (39.3).
Impact
Cause RADLY
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
75,594
Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Sub-industry
Drug Retail
SASB industry
Drug Retailers
Headquarters
Sp, Brazil
Share classes
RADLY
ADR
Description
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
Material causes
Ethos considers the following causes material for Raia Drogasil, based on its industry sub-industry Drug Retail. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.